





























Chronic	 heart	 failure	 is	 often	 accompanied	 by	 comorbidities	 including	
obesity	being	the	major	one.	It	significantly	aggravates	the	course	of	the	disease	
and	clinical	outcome.	Changes	 in	the	plasma	concentration	of	 lipids	 in	chronic	
heart	 failure	 were	 demonstrated	 by	 many	 studies.	 Recently	 a	 considerable	
number	of	works	has	appeared	 in	which	a	negative	 influence	of	both	high	and	






heart	 failure	 functional	 class	 I-III	 having	 normal	 body	 weight,	 I-III	 degree	
abdominal	 obesity	 or	 being	 overweight.	 Patients	 underwent	 complete	 blood	
count	and	biochemical	blood	analysis;	instrumental	examination	was	performed	
according	 to	 the	existing	guidelines	 for	 the	diagnosis	and	 treatment	of	chronic	
heart	failure.	Statistical	processing	of	the	obtained	material	was	performed	using	
an	advanced	analytics	software	package	Statistica	6.0.	
	 Results	 and	 discussion.	 Both	 atherogenic	 and	 antiatherogenic	
components	of	lipid	metabolism	predominated	in	females.	Age-related	changes	













Chronic	heart	failure	 (CHF)	 is	often	accompanied	by	comorbidities	 including	obesity	being	
the	 major	 one.	 It	 significantly	 aggravates	 the	 course	 of	 the	 disease	 and	 clinical	 outcome	 [1].	
Changes	 in	 the	plasma	concentration	of	 lipids	 in	CHF	were	demonstrated	by	many	studies	 [2-6].	
The	 epidemiological	 studies	 demonstrated	 that	 dyslipidemia	 can	 directly	 influence	 the	
development	and	progression	of	CHF	 [11].	Low	 levels	of	atherogenic	 lipids	and	elevated	 levels	of	




is	 the	 basis	 for	 primary	 and	 secondary	 prevention	 [3].	 Several	 preclinical	 and	 clinical	 studies	
allowed	 the	 use	 of	 statins	 in	 patients	 with	 CHF	 [4,	 7,	 10]	 concentrating	 their	 arguments	 on	







the	 prognostic	 significance	 of	 lipid	 levels	 in	 these	 patients,	 the	 chosen	 direction	 of	 research	 is	
timely	and	relevant.	





weight,	 I-III	degree	 abdominal	obesity	or	being	overweight.	 Patients	were	 treated	 in	 the	Central	
Clinical	Hospital	No	4,	Zaporizhzhya.	The	diagnosis	of	CHF	was	made	according	to	the	Guidelines	
of	 the	Ukrainian	Association	of	Cardiology	and	 the	Ukrainian	Association	of	Specialists	 in	Heart	





The	 study	 was	 conducted	 according	 to	 the	 standards	 of	 Good	 Clinical	 Practice	 and	 the	
principles	 of	 the	 Helsinki	 Declaration.	 The	 Ethical	 Committee	 of	 Zaporizhzhya	 State	 Medical	
University	approved	the	protocol;	only	patients	who	gave	written	informed	consent	were	included	
in	this	study.	
Patients	 underwent	 complete	 blood	 count	 and	 biochemical	 blood	 analysis,	 instrumental	
examination	was	performed	according	to	the	existing	guidelines	 for	the	diagnosis	and	treatment	
of	 CHF.	 The	 levels	 of	 total	 cholesterol	 (TC),	 high-density	 lipoprotein	 cholesterol	 (HDL-С),	
triglycerides	 (TG)	were	determined.	The	 level	of	 low-density	 lipoprotein	 cholesterol	 (LDL-C)	was	
calculated	by	the	Friedewald	formula:	LDL-C=TC–HDL-C–(0.45	x	TG).	The	level	of	very-low-density	
lipoproteins	cholesterol	 (VLDL-C)	was	determined	according	 to	 the	 formula:	VLDL-C=TG/2.2.	The	
atherogenic	coefficient	(AC)	was	calculated	by	the	formula	proposed	by	Klimov	AM	–	AC	=	(TC–HDL-










According	 to	 the	 sample	 size	 and	 distribution	 of	 values	 parametric	 (Student’s	 t-test)	 and	
nonparametric	 statistical	 methods	 (Mann-Whitney	 U	 test)	 were	 used.	 The	 comparison	 of	
categorical	 variables	 was	 performed	 using	 bilateral	 Fisher’s	 exact	 test	 or	 chi-square	 test.	 The	
relations	 between	 the	 indicators	 were	 assessed	 using	 correlation	 analysis	 and	 calculating	 the	




General	 characteristics	 and	 lipid	 profile	 in	 CHF	 secondary	 to	 overweight	 and	 obesity	
according	to	gender	are	presented	in	Table	1.	It	should	be	noted	that	women	were	older	(4.4	years,	
p<0.05).	CHF	FC	did	not	have	any	gender-based	differences,	and	the	BMI	 in	men	was	significantly	
lower	than	that	 in	women	 (5.9%).	 In	women	the	 levels	of	TC,	HDL-C,	VLDL-C	and	TG	were	higher	
than	in	men	–	by	8.3%,	11.6%,	8.9%	and	9.3%,	respectively	(p<0.05).	The	level	of	LDL-C	in	women	was	



























TG,	and	 low	 levels	of	anti-atherogenic	HDL-C	predominated	 in	women.	The	 frequency	of	normal	
and	low	levels	of	TC,	HDL-C,	LDL-C,	VLDL-C	and	TG	was	greater	in	men.	Elevated	levels	of	the	AC,	











































































The	 results	of	studying	age-related	peculiarities	of	 lipid	metabolism	 in	patients	with	CHF	
secondary	 to	overweight	and	obesity	are	presented	 in	Table	3.	Among	young	patients	men	 (38%)	
dominated;	women	(54.4%)	were	more	often	observed	among	elderly	patients.	Equal	distribution	of	
patients	 according	 to	 gender	was	 observed	 among	middle-aged	patients;	 among	 senile	patients	
women	dominated.	The	number	of	women	among	elderly	patients	was	greater	compared	to	young	
and	 middle-aged	 patients	 -	 41.7%	 and	 22.7%,	 respectively,	 p<0.05.	 The	 opposite	 changes	 were	
observed	among	men.	The	progression	of	CHF	with	age	manifested	as	a	 reliable	 increase	 in	 the	
average	value	of	FC	of	the	disease	was	observed.	In	the	first	two	age	groups	there	was	a	tendency	





observed	 in	 young	 patients;	 minimum	 values	 were	 detected	 in	 senile	 patients.	 There	 was	 a	
tendency	to	increase	in	the	concentration	of	HDL-C	with	increasing	age.	Maximum	values	of	VLDL-
C	were	observed	in	young	and	middle-aged	patients	significantly	yielding	those	in	elderly	(by	49.3%	
and	33.3%,	respectively)	and	senile	 (by	69.7%	and	51.5%,	respectively)	patients.	The	 level	of	TG	 in	
young	 patients	 exceeded	 that	 in	 elderly	 and	 senile	 patients	 -	 by	 48.5%	 and	 67.8%,	 respectively,	







young	patients	 this	parameter	exceeded	 that	 in	elderly	and	senile	patients	–	by	27.2%	and	31.5%,	




and	 61.8%,	 respectively,	 p<0.05.	 There	 were	 significant	 correlations	 of	 age	 with	 the	 following	
















Women,	n	(%)	 4	(31)	 31	(50)	 72	(72.7)*1	 21	(55.3)	
Men,	n	(%)	 9	(69)	 31	(50)	 27	(27.3)*1	 17	(44.7)	
CHF,	FC	 1.54±0.78	 1.66±0.75	 2.05±0.71*1	 2.66±0.58*12	
BMI,	kg/m2	 34.3±5.43	 32.7±6.66	 31.2±5.70	 29.9±5.24*1	
TC,	mmol/l	 5.68±1.38	 5.29±1.30	 5.34±1.64	 5.09±1.18	
HDL-C,	mmol/l	 1.17±0.32	 1.26±0.35	 1.33±0.33	 1.32±0.32	
LDL-C,	mmol/l	 3.38±1.07	 3.15±1.12	 3.25±1.40	 3.10±0.99	
VLDL-C,	mmol/l	 1.12±0.72	 1.0±0.98	 0.75±0.41*1	 0.66±0.32*1	
TG,	mmol/l	 2.45±1.58	 2.21±1.17	 1.65±0.90*1	 1.46±0.70*1	
AC	 3.97±0.94	 3.41±1.35	 3.12±1.08*	 3.02±1.20*	
LDL-C/HDL-C	ratio	 2.95±0.86	 2.64±1.11	 2.50±0.91	 2.46±0.95	








C	 and	 LDL-C	 significant	differences	 in	 age	 are	not	 established.	The	 increase	 in	parameters	was	
observed	 in	young	patients.	Maximum	prevalence	of	elevated	VLDL-C	 levels	was	also	detected	 in	
young	patients	exceeding	 those	 in	middle-aged,	elderly	and	senile	patients	 -	 	by	20.4%,	29%	and	
33%,	respectively,	p<0.05.	There	were	observed	the	opposite	changes	in	frequency	of	normal	levels	











The	AC	 in	senile	patients	yielded	 that	 in	young	patients	 (by	32.2%,	p<0.05).	There	were	observed	
the	opposite	changes	in	the	prevalence	of	normal	levels	of	AC	increasing	with	age.	There	were	no	






















































































































Thus,	 in	 CHF	 secondary	 to	 overweight	 and	 obesity	 more	 significant	 disorders	 of	 lipid	
metabolism	manifested	themselves	as	a	predominance	of	atherogenic	TC,	VLDL-C	and	TG	occurred	
in	women.	At	the	same	time,	a	significantly	higher	level	of	antiatherogenic	HDL-C	was	observed	in	
women,	which	may	be	due	 to	 the	higher	 range	of	normal	values,	 the	prevalence	of	 the	BMI	and	










opposite	 picture	 regarding	 the	 frequency	 of	 detection	 of	 normal	 levels	 of	 these	 parameters	
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